Building a Medical Home for Multiply Diagnosed HIV positive Homeless Populations - Demonstration Sites Project
Page 2

Due to the transient nature of the lives of homeless people suffering from HIV, HRSA perceives that it is very much essential to strategically coordinate efforts to engage and retain these individuals in a care facility that is more than capable of meeting their unique needs as HIV patients.

In addition, the applicants of this program will have to adopt a set of organizational structures characterized as having integrated or co-located strategies for their successful service provision.

To support this, the Health Resources and Services Administration is set to administer funds in the amount of $2,400,000 to worthy applicants.

The institutions and organizations who will be deemed eligible to submit an application under this program are the following:

a) State and Local Governments

b) Academic Institutions of Higher Education

c) Local health departments

d) Community Health Centers

e) Faith-based and community-based organizations

f) Native American Tribal Governments

g) Nonprofit organizations

h) City or Township Governments

i) Special District Governments

The United States Department of Health and Human Services, the mother agency that's funding the Building a Medical Home for Multiply Diagnosed HIV positive Homeless Populations – Demonstration Sites Project, is the country's leading agency that's intended for protecting the health of all Americans and providing essential human services to all.

Building a Medical Home for Multiply Diagnosed HIV positive Homeless Populations - Demonstration Sites Project
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on grants for youth programs and home improvement grants.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Genomic Advances to Wound Repair
The National Institutes of Health has coordinated with the National Institute of Nursing Research (NINR) to establish a program called Genomic Advances to Wound Repair in an effort to jump-start research studies that have the potential to deepen the understanding of genomic mechanism associated with the repair and development of wounds that are chronic in nature, which implies that these wounds have failed to enter into a reparative process after three months.

---

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

The Collaborative Islet Transplantation Registry Program
The National Institutes of Health has formed a partnership with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in order to establish the The Collaborative Islet Transplantation Registry Program wherein both agencies seek to invite applications that intend to continue initiatives started through the Collaborative Islet Transplantation Registry (CITR).

---